fanta.bio Sample: CNhs11251
20174 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| FOXP1 SRX736067 | LNCAP Prostate | 3065 / 28717 (10.7%) | 1135 / 287170 (0.4%) | −324.0 | −324.0 | 27.00 |
| SCML2 SRX644728 | 293 Kidney | 2145 / 28717 (7.5%) | 823 / 287170 (0.3%) | −324.0 | −324.0 | 26.06 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 2402 / 28717 (8.4%) | 926 / 287170 (0.3%) | −324.0 | −324.0 | 25.94 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 3308 / 28717 (11.5%) | 1360 / 287170 (0.5%) | −324.0 | −324.0 | 24.32 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 3393 / 28717 (11.8%) | 1399 / 287170 (0.5%) | −324.0 | −324.0 | 24.25 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 569 / 28717 (2.0%) | 284 / 287170 (0.1%) | −324.0 | −324.0 | 20.04 |
| HIF1A SRX11007095 | HK-2 Kidney | 2507 / 28717 (8.7%) | 1469 / 287170 (0.5%) | −324.0 | −324.0 | 17.07 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1189 / 28717 (4.1%) | 746 / 287170 (0.3%) | −324.0 | −324.0 | 15.94 |
| MYH11 SRX265221 | ME-1 Blood | 1246 / 28717 (4.3%) | 815 / 287170 (0.3%) | −324.0 | −324.0 | 15.29 |
| HIF1A SRX20663235 | HK-2 Kidney | 604 / 28717 (2.1%) | 405 / 287170 (0.1%) | −324.0 | −324.0 | 14.91 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1710 / 28717 (6.0%) | 1328 / 287170 (0.5%) | −324.0 | −324.0 | 12.88 |
| MED1 SRX9419945 | BT-474 Breast | 4502 / 28717 (15.7%) | 4261 / 287170 (1.5%) | −324.0 | −324.0 | 10.57 |
| MED1 SRX9419944 | BT-474 Breast | 4370 / 28717 (15.2%) | 4207 / 287170 (1.5%) | −324.0 | −324.0 | 10.39 |
| MED1 SRX9419946 | BT-474 Breast | 4563 / 28717 (15.9%) | 4495 / 287170 (1.6%) | −324.0 | −324.0 | 10.15 |
| BRD4 SRX9419936 | BT-474 Breast | 4530 / 28717 (15.8%) | 4523 / 287170 (1.6%) | −324.0 | −324.0 | 10.02 |
| EZH2 SRX2146136 | LNCAP Prostate | 11523 / 28717 (40.1%) | 11539 / 287170 (4.0%) | −324.0 | −324.0 | 9.99 |
| BRD4 SRX9419938 | BT-474 Breast | 4493 / 28717 (15.6%) | 4514 / 287170 (1.6%) | −324.0 | −324.0 | 9.95 |
| MED1 SRX9419947 | BT-474 Breast | 4410 / 28717 (15.4%) | 4434 / 287170 (1.5%) | −324.0 | −324.0 | 9.95 |
| BRD4 SRX9419935 | BT-474 Breast | 4278 / 28717 (14.9%) | 4413 / 287170 (1.5%) | −324.0 | −324.0 | 9.69 |
| BRD4 SRX9419937 | BT-474 Breast | 4289 / 28717 (14.9%) | 4454 / 287170 (1.6%) | −324.0 | −324.0 | 9.63 |
| BRD4 SRX736201 | 90-8TL Neural | 7594 / 28717 (26.4%) | 10530 / 287170 (3.7%) | −324.0 | −324.0 | 7.21 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2603 / 28717 (9.1%) | 4069 / 287170 (1.4%) | −324.0 | −324.0 | 6.40 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 905 / 28717 (3.2%) | 1445 / 287170 (0.5%) | −324.0 | −324.0 | 6.26 |
| PAF1 SRX1873455 | SEM Blood | 1303 / 28717 (4.5%) | 3133 / 287170 (1.1%) | −324.0 | −324.0 | 4.16 |
| AFF1 SRX15203358 | Acute lymphoid leukemia Blood | 1363 / 28717 (4.7%) | 3372 / 287170 (1.2%) | −324.0 | −324.0 | 4.04 |
| BRPF3 SRX796085 | RKO Digestive tract | 2032 / 28717 (7.1%) | 5554 / 287170 (1.9%) | −324.0 | −324.0 | 3.66 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1588 / 28717 (5.5%) | 4384 / 287170 (1.5%) | −324.0 | −324.0 | 3.62 |
| BRD1 SRX286203 | RKO Digestive tract | 2285 / 28717 (8.0%) | 6350 / 287170 (2.2%) | −324.0 | −324.0 | 3.60 |
| KMT2B DRX059615 | HB1119 Blood | 1616 / 28717 (5.6%) | 4532 / 287170 (1.6%) | −324.0 | −324.0 | 3.57 |
| KMT2B DRX059614 | HB1119 Blood | 1596 / 28717 (5.6%) | 4522 / 287170 (1.6%) | −324.0 | −324.0 | 3.53 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 2058 / 28717 (7.2%) | 5892 / 287170 (2.1%) | −324.0 | −324.0 | 3.49 |
| KAT7 SRX101303 | RKO Digestive tract | 2721 / 28717 (9.5%) | 7927 / 287170 (2.8%) | −324.0 | −324.0 | 3.43 |
| LEO1 SRX1873456 | SEM Blood | 3080 / 28717 (10.7%) | 9340 / 287170 (3.3%) | −324.0 | −324.0 | 3.30 |
| JADE3 DRX234809 | 293 Kidney | 1838 / 28717 (6.4%) | 5778 / 287170 (2.0%) | −324.0 | −324.0 | 3.18 |
| Epitope tags SRX10549776 | K-562 Blood | 2570 / 28717 (8.9%) | 8251 / 287170 (2.9%) | −324.0 | −324.0 | 3.11 |
| SETD1A SRX23734380 | MOLM-13 Blood | 1861 / 28717 (6.5%) | 6003 / 287170 (2.1%) | −324.0 | −324.0 | 3.10 |
| EP300 ERX626811 | U-937 Blood | 2350 / 28717 (8.2%) | 7591 / 287170 (2.6%) | −324.0 | −324.0 | 3.10 |
| ING5 SRX286202 | RKO Digestive tract | 2501 / 28717 (8.7%) | 8083 / 287170 (2.8%) | −324.0 | −324.0 | 3.09 |
| EP300 ERX626821 | U-937 Blood | 2339 / 28717 (8.1%) | 7578 / 287170 (2.6%) | −324.0 | −324.0 | 3.09 |
| Epitope tags SRX10549778 | K-562 Blood | 2000 / 28717 (7.0%) | 6483 / 287170 (2.3%) | −324.0 | −324.0 | 3.08 |
| BRPF3 SRX796086 | RKO Digestive tract | 2800 / 28717 (9.8%) | 9168 / 287170 (3.2%) | −324.0 | −324.0 | 3.05 |
| BRPF3 SRX796084 | RKO Digestive tract | 2931 / 28717 (10.2%) | 9650 / 287170 (3.4%) | −324.0 | −324.0 | 3.04 |
| SETD1A SRX23734379 | MOLM-13 Blood | 2271 / 28717 (7.9%) | 7651 / 287170 (2.7%) | −324.0 | −324.0 | 2.97 |
| BRD4 SRX17989514 | PBMC Blood | 2082 / 28717 (7.3%) | 7050 / 287170 (2.5%) | −324.0 | −324.0 | 2.95 |
| BRD4 SRX3591435 | B-CLL cells Blood | 2888 / 28717 (10.1%) | 9939 / 287170 (3.5%) | −324.0 | −324.0 | 2.91 |
| BRD4 SRX3591434 | B-CLL cells Blood | 3035 / 28717 (10.6%) | 10492 / 287170 (3.7%) | −324.0 | −324.0 | 2.89 |
| BRD4 SRX3591438 | B-CLL cells Blood | 2745 / 28717 (9.6%) | 9499 / 287170 (3.3%) | −324.0 | −324.0 | 2.89 |
| Epitope tags DRX443510 | 293 Kidney | 2787 / 28717 (9.7%) | 9738 / 287170 (3.4%) | −324.0 | −324.0 | 2.86 |
| BRD4 SRX3591437 | B-CLL cells Blood | 2759 / 28717 (9.6%) | 9756 / 287170 (3.4%) | −324.0 | −324.0 | 2.83 |
| AFF1 SRX10484575 | RS4-11 Blood | 2786 / 28717 (9.7%) | 10066 / 287170 (3.5%) | −324.0 | −324.0 | 2.77 |
| KMT2A SRX5732680 | MOLM-13 Blood | 2458 / 28717 (8.6%) | 8944 / 287170 (3.1%) | −324.0 | −324.0 | 2.75 |
| MYC SRX1497394 | RAJI Blood | 2494 / 28717 (8.7%) | 9186 / 287170 (3.2%) | −324.0 | −324.0 | 2.71 |
| MEAF6 DRX300417 | 293 Kidney | 2872 / 28717 (10.0%) | 10624 / 287170 (3.7%) | −324.0 | −324.0 | 2.70 |
| BRD4 SRX3591431 | B-CLL cells Blood | 2579 / 28717 (9.0%) | 9738 / 287170 (3.4%) | −324.0 | −324.0 | 2.65 |
| STAT1 SRX23678707 | K-562 Blood | 2593 / 28717 (9.0%) | 9829 / 287170 (3.4%) | −324.0 | −324.0 | 2.64 |
| MEN1 SRX11712604 | K-562 Blood | 2527 / 28717 (8.8%) | 9597 / 287170 (3.3%) | −324.0 | −324.0 | 2.63 |
| MEAF6 DRX234811 | 293 Kidney | 3136 / 28717 (10.9%) | 12019 / 287170 (4.2%) | −324.0 | −324.0 | 2.61 |
| STAT1 SRX23678708 | K-562 Blood | 2804 / 28717 (9.8%) | 10760 / 287170 (3.7%) | −324.0 | −324.0 | 2.61 |
| JADE3 DRX300415 | 293 Kidney | 2747 / 28717 (9.6%) | 10671 / 287170 (3.7%) | −324.0 | −324.0 | 2.57 |
| CXXC1 SRX1424886 | SEM Blood | 2533 / 28717 (8.8%) | 9934 / 287170 (3.5%) | −324.0 | −324.0 | 2.55 |
| AGO2 SRX4708039 | Hep G2 Liver | 3071 / 28717 (10.7%) | 12124 / 287170 (4.2%) | −324.0 | −324.0 | 2.53 |
| HDAC1 SRX17989500 | PBMC Blood | 2892 / 28717 (10.1%) | 11427 / 287170 (4.0%) | −324.0 | −324.0 | 2.53 |
| KMT2A SRX2281247 | SEM Blood | 2992 / 28717 (10.4%) | 11955 / 287170 (4.2%) | −324.0 | −324.0 | 2.50 |
| BRD4 SRX17989516 | PBMC Blood | 2575 / 28717 (9.0%) | 10294 / 287170 (3.6%) | −324.0 | −324.0 | 2.50 |
| KMT2A SRX20870810 | SEM Blood | 2750 / 28717 (9.6%) | 11181 / 287170 (3.9%) | −324.0 | −324.0 | 2.46 |
| HDAC1 SRX17989497 | PBMC Blood | 3407 / 28717 (11.9%) | 13948 / 287170 (4.9%) | −324.0 | −324.0 | 2.44 |
| HDAC1 SRX17989499 | PBMC Blood | 3145 / 28717 (11.0%) | 13402 / 287170 (4.7%) | −324.0 | −324.0 | 2.35 |
| HDAC1 SRX17989501 | PBMC Blood | 3855 / 28717 (13.4%) | 16719 / 287170 (5.8%) | −324.0 | −324.0 | 2.31 |
| ZNF384 SRX17159338 | JIH-5 Blood | 3440 / 28717 (12.0%) | 15241 / 287170 (5.3%) | −324.0 | −324.0 | 2.26 |
| RAG2 SRX1046558 | Thymus Blood | 3594 / 28717 (12.5%) | 16384 / 287170 (5.7%) | −324.0 | −324.0 | 2.19 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1907 / 28717 (6.6%) | 41691 / 287170 (14.5%) | −324.0 | −324.0 | 0.46 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1874 / 28717 (6.5%) | 42027 / 287170 (14.6%) | −324.0 | −324.0 | 0.45 |
| ESR1 SRX4367193 | MCF-7 Breast | 1820 / 28717 (6.3%) | 41042 / 287170 (14.3%) | −324.0 | −324.0 | 0.44 |
| ESR1 SRX7624157 | MCF-7 Breast | 1537 / 28717 (5.4%) | 35610 / 287170 (12.4%) | −324.0 | −324.0 | 0.43 |
| TCF12 SRX190356 | SK-N-SH Neural | 1566 / 28717 (5.5%) | 36536 / 287170 (12.7%) | −324.0 | −324.0 | 0.43 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 1316 / 28717 (4.6%) | 32477 / 287170 (11.3%) | −324.0 | −324.0 | 0.41 |
| SS18 SRX3468047 | Fibroblasts Others | 1388 / 28717 (4.8%) | 34927 / 287170 (12.2%) | −324.0 | −324.0 | 0.40 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 1328 / 28717 (4.6%) | 33713 / 287170 (11.7%) | −324.0 | −324.0 | 0.39 |
| GATA3 SRX190194 | SK-N-SH Neural | 1317 / 28717 (4.6%) | 33555 / 287170 (11.7%) | −324.0 | −324.0 | 0.39 |
| AR SRX1067070 | LHSAR Prostate | 1320 / 28717 (4.6%) | 34379 / 287170 (12.0%) | −324.0 | −324.0 | 0.38 |
| PBX4 SRX2731658 | PC-3 Prostate | 1730 / 28717 (6.0%) | 46007 / 287170 (16.0%) | −324.0 | −324.0 | 0.38 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 1008 / 28717 (3.5%) | 27756 / 287170 (9.7%) | −324.0 | −324.0 | 0.36 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 1122 / 28717 (3.9%) | 31371 / 287170 (10.9%) | −324.0 | −324.0 | 0.36 |
| JUNB SRX8488088 | SUM 229PE Breast | 1059 / 28717 (3.7%) | 29796 / 287170 (10.4%) | −324.0 | −324.0 | 0.36 |
| ESR1 SRX176861 | MCF-7 Breast | 966 / 28717 (3.4%) | 27202 / 287170 (9.5%) | −324.0 | −324.0 | 0.36 |
| FOS SRX150476 | MCF 10A Breast | 992 / 28717 (3.5%) | 27968 / 287170 (9.7%) | −324.0 | −324.0 | 0.35 |
| SMARCA4 SRX5212362 | Mel270 Others | 967 / 28717 (3.4%) | 27605 / 287170 (9.6%) | −324.0 | −324.0 | 0.35 |
| JUNB SRX8488073 | SUM 229PE Breast | 1009 / 28717 (3.5%) | 29118 / 287170 (10.1%) | −324.0 | −324.0 | 0.35 |
| SMARCA2 SRX8119677 | MeT-5A Others | 903 / 28717 (3.1%) | 26760 / 287170 (9.3%) | −324.0 | −324.0 | 0.34 |
| MAU2 SRX15710550 | Fibroblasts Others | 901 / 28717 (3.1%) | 26745 / 287170 (9.3%) | −324.0 | −324.0 | 0.34 |
| ESR1 SRX176860 | MCF-7 Breast | 907 / 28717 (3.2%) | 27236 / 287170 (9.5%) | −324.0 | −324.0 | 0.33 |
| FOS SRX150478 | MCF 10A Breast | 1167 / 28717 (4.1%) | 35252 / 287170 (12.3%) | −324.0 | −324.0 | 0.33 |
| AR SRX1067071 | LHSAR Prostate | 993 / 28717 (3.5%) | 30208 / 287170 (10.5%) | −324.0 | −324.0 | 0.33 |
| SMARCA4 SRX5212371 | Mel270 Others | 799 / 28717 (2.8%) | 24458 / 287170 (8.5%) | −324.0 | −324.0 | 0.33 |
| FOXA1 SRX176862 | MCF-7 Breast | 787 / 28717 (2.7%) | 24174 / 287170 (8.4%) | −324.0 | −324.0 | 0.33 |
| SMARCA4 SRX5212357 | Mel270 Others | 806 / 28717 (2.8%) | 24819 / 287170 (8.6%) | −324.0 | −324.0 | 0.32 |
| FOS SRX150517 | MCF 10A Breast | 884 / 28717 (3.1%) | 27959 / 287170 (9.7%) | −324.0 | −324.0 | 0.32 |
| FOS SRX150477 | MCF 10A Breast | 1067 / 28717 (3.7%) | 34440 / 287170 (12.0%) | −324.0 | −324.0 | 0.31 |
| ESR1 SRX20282961 | MCF-7 Breast | 718 / 28717 (2.5%) | 23603 / 287170 (8.2%) | −324.0 | −324.0 | 0.30 |
| ESR1 SRX371478 | MCF-7 Breast | 724 / 28717 (2.5%) | 23893 / 287170 (8.3%) | −324.0 | −324.0 | 0.30 |
| FOS SRX4192880 | MCF 10A Breast | 844 / 28717 (2.9%) | 27986 / 287170 (9.7%) | −324.0 | −324.0 | 0.30 |
| SMARCA4 SRX5212366 | Mel270 Others | 716 / 28717 (2.5%) | 23834 / 287170 (8.3%) | −324.0 | −324.0 | 0.30 |
| JUN SRX17561461 | LPS141 Adipocyte | 737 / 28717 (2.6%) | 25120 / 287170 (8.7%) | −324.0 | −324.0 | 0.29 |
| YAP1 SRX757325 | H2052 Lung | 1026 / 28717 (3.6%) | 35827 / 287170 (12.5%) | −324.0 | −324.0 | 0.29 |
| FOS SRX4192879 | MCF 10A Breast | 625 / 28717 (2.2%) | 22017 / 287170 (7.7%) | −324.0 | −324.0 | 0.28 |
| YAP1 SRX757326 | H2052 Lung | 840 / 28717 (2.9%) | 32087 / 287170 (11.2%) | −324.0 | −324.0 | 0.26 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 529 / 28717 (1.8%) | 20507 / 287170 (7.1%) | −324.0 | −324.0 | 0.26 |
| JUNB SRX10119386 | MCF 10A Breast | 488 / 28717 (1.7%) | 19094 / 287170 (6.6%) | −322.8 | −320.3 | 0.26 |
| ESR1 SRX20282939 | MCF-7 Breast | 668 / 28717 (2.3%) | 22183 / 287170 (7.7%) | −322.2 | −319.7 | 0.30 |
| JUN SRX6582171 | GM07492 Others | 1135 / 28717 (4.0%) | 29488 / 287170 (10.3%) | −320.6 | −318.1 | 0.38 |
| JUNB SRX8488074 | SUM 229PE Breast | 763 / 28717 (2.7%) | 23620 / 287170 (8.2%) | −318.3 | −315.9 | 0.32 |
| AGO2 SRX6783957 | Hep G2 Liver | 2041 / 28717 (7.1%) | 7207 / 287170 (2.5%) | −318.2 | −315.8 | 2.83 |
| AGO2 SRX6783958 | Hep G2 Liver | 2014 / 28717 (7.0%) | 7052 / 287170 (2.5%) | −318.0 | −315.5 | 2.86 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 508 / 28717 (1.8%) | 19294 / 287170 (6.7%) | −317.7 | −315.3 | 0.26 |
| NR3C1 SRX2609664 | HASM2 Lung | 806 / 28717 (2.8%) | 24282 / 287170 (8.5%) | −317.4 | −314.9 | 0.33 |
| EP300 SRX2671813 | Fibroblasts Others | 450 / 28717 (1.6%) | 18220 / 287170 (6.3%) | −316.6 | −314.1 | 0.25 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1915 / 28717 (6.7%) | 40388 / 287170 (14.1%) | −315.8 | −313.3 | 0.47 |
| ESR1 SRX20282960 | MCF-7 Breast | 682 / 28717 (2.4%) | 22211 / 287170 (7.7%) | −315.8 | −313.3 | 0.31 |
| ESR1 SRX371469 | MCF-7 Breast | 628 / 28717 (2.2%) | 21244 / 287170 (7.4%) | −313.9 | −311.5 | 0.30 |
| JUNB SRX4192882 | MCF 10A Breast | 432 / 28717 (1.5%) | 17744 / 287170 (6.2%) | −311.7 | −309.2 | 0.24 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 1411 / 28717 (4.9%) | 3827 / 287170 (1.3%) | −311.6 | −309.2 | 3.69 |
| ESR1 SRX7624156 | MCF-7 Breast | 980 / 28717 (3.4%) | 26767 / 287170 (9.3%) | −310.2 | −307.8 | 0.37 |
| MEN1 SRX14030471 | MV-4-11 Blood | 1726 / 28717 (6.0%) | 5521 / 287170 (1.9%) | −309.8 | −307.4 | 3.13 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 1034 / 28717 (3.6%) | 27527 / 287170 (9.6%) | −308.4 | −306.0 | 0.38 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 830 / 28717 (2.9%) | 24360 / 287170 (8.5%) | −308.3 | −305.9 | 0.34 |
| YAP1 SRX5718140 | 293 Kidney | 1026 / 28717 (3.6%) | 27393 / 287170 (9.5%) | −308.1 | −305.6 | 0.37 |
| ESR1 SRX20282972 | MCF-7 Breast | 670 / 28717 (2.3%) | 21741 / 287170 (7.6%) | −307.6 | −305.2 | 0.31 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 1471 / 28717 (5.1%) | 33897 / 287170 (11.8%) | −307.5 | −305.1 | 0.43 |
| BRD4 SRX3591429 | B-CLL cells Blood | 1679 / 28717 (5.8%) | 5296 / 287170 (1.8%) | −307.1 | −304.6 | 3.17 |
| ESR1 SRX1531791 | MCF-7 Breast | 580 / 28717 (2.0%) | 20179 / 287170 (7.0%) | −306.0 | −303.6 | 0.29 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 793 / 28717 (2.8%) | 23638 / 287170 (8.2%) | −304.5 | −302.1 | 0.34 |
| JUNB SRX8488089 | SUM 229PE Breast | 581 / 28717 (2.0%) | 20136 / 287170 (7.0%) | −304.2 | −301.8 | 0.29 |
| NR3C1 SRX2609665 | HASM2 Lung | 643 / 28717 (2.2%) | 21163 / 287170 (7.4%) | −303.6 | −301.2 | 0.30 |
| ESR1 SRX371476 | MCF-7 Breast | 443 / 28717 (1.5%) | 17692 / 287170 (6.2%) | −303.4 | −301.0 | 0.25 |
| FOSL2 SRX190296 | SK-N-SH Neural | 793 / 28717 (2.8%) | 23599 / 287170 (8.2%) | −303.4 | −301.0 | 0.34 |
| JUN SRX6582172 | Fibroblasts Others | 782 / 28717 (2.7%) | 23419 / 287170 (8.2%) | −303.3 | −300.9 | 0.33 |
| ESR1 SRX20282954 | MCF-7 Breast | 663 / 28717 (2.3%) | 21470 / 287170 (7.5%) | −302.9 | −300.5 | 0.31 |
| JUND SRX190357 | SK-N-SH Neural | 748 / 28717 (2.6%) | 22824 / 287170 (7.9%) | −301.8 | −299.4 | 0.33 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 1317 / 28717 (4.6%) | 3472 / 287170 (1.2%) | −300.3 | −297.9 | 3.79 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 1192 / 28717 (4.2%) | 29559 / 287170 (10.3%) | −299.4 | −297.0 | 0.40 |
| NR3C1 SRX2609659 | HASM2 Lung | 691 / 28717 (2.4%) | 21797 / 287170 (7.6%) | −298.8 | −296.5 | 0.32 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 782 / 28717 (2.7%) | 23243 / 287170 (8.1%) | −298.0 | −295.6 | 0.34 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 1041 / 28717 (3.6%) | 27247 / 287170 (9.5%) | −297.8 | −295.4 | 0.38 |
| ESR1 SRX371479 | MCF-7 Breast | 577 / 28717 (2.0%) | 19835 / 287170 (6.9%) | −297.0 | −294.6 | 0.29 |
| FOXA1 SRX1161177 | MCF-7 Breast | 641 / 28717 (2.2%) | 20906 / 287170 (7.3%) | −296.8 | −294.5 | 0.31 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 594 / 28717 (2.1%) | 20115 / 287170 (7.0%) | −296.8 | −294.4 | 0.30 |
| FOXA1 SRX176863 | MCF-7 Breast | 771 / 28717 (2.7%) | 23012 / 287170 (8.0%) | −296.4 | −294.1 | 0.34 |
| JUNB SRX10119383 | MCF 10A Breast | 383 / 28717 (1.3%) | 16359 / 287170 (5.7%) | −295.8 | −293.5 | 0.23 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 483 / 28717 (1.7%) | 18151 / 287170 (6.3%) | −295.3 | −292.9 | 0.27 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 1457 / 28717 (5.1%) | 33218 / 287170 (11.6%) | −295.1 | −292.8 | 0.44 |
| NR3C1 SRX2609666 | HASM2 Lung | 563 / 28717 (2.0%) | 19503 / 287170 (6.8%) | −294.1 | −291.8 | 0.29 |
| ING2 SRX286201 | RKO Digestive tract | 2376 / 28717 (8.3%) | 9650 / 287170 (3.4%) | −294.1 | −291.8 | 2.46 |
| VGLL1 SRX24602130 | BT-20 Breast | 629 / 28717 (2.2%) | 20613 / 287170 (7.2%) | −294.0 | −291.6 | 0.31 |
| ESR1 SRX10365535 | MCF-7 Breast | 481 / 28717 (1.7%) | 18068 / 287170 (6.3%) | −293.7 | −291.4 | 0.27 |
| NR3C1 SRX2609661 | HASM2 Lung | 662 / 28717 (2.3%) | 21150 / 287170 (7.4%) | −293.7 | −291.4 | 0.31 |
| NR3C1 SRX2609662 | HASM2 Lung | 721 / 28717 (2.5%) | 22092 / 287170 (7.7%) | −292.9 | −290.6 | 0.33 |
| JUN SRX4192884 | MCF 10A Breast | 493 / 28717 (1.7%) | 18250 / 287170 (6.4%) | −292.7 | −290.4 | 0.27 |
| TP53 SRX396254 | Fibroblasts Others | 1455 / 28717 (5.1%) | 4264 / 287170 (1.5%) | −292.4 | −290.0 | 3.41 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 1254 / 28717 (4.4%) | 3249 / 287170 (1.1%) | −291.4 | −289.1 | 3.86 |
| KMT2A SRX15203354 | Acute lymphoid leukemia Blood | 1996 / 28717 (7.0%) | 7340 / 287170 (2.6%) | −291.4 | −289.1 | 2.72 |
| YAP1 SRX10119364 | MCF 10A Breast | 489 / 28717 (1.7%) | 18125 / 287170 (6.3%) | −291.0 | −288.7 | 0.27 |
| JUN SRX883584 | MDA-MB-231 Breast | 973 / 28717 (3.4%) | 25967 / 287170 (9.0%) | −290.9 | −288.5 | 0.37 |
| Epitope tags SRX2529782 | RAJI Blood | 2197 / 28717 (7.7%) | 8580 / 287170 (3.0%) | −290.8 | −288.5 | 2.56 |
| Epitope tags SRX9252033 | MOLM-13 Blood | 2245 / 28717 (7.8%) | 8879 / 287170 (3.1%) | −290.7 | −288.4 | 2.53 |
| Epitope tags SRX10549777 | K-562 Blood | 4076 / 28717 (14.2%) | 21578 / 287170 (7.5%) | −289.8 | −287.5 | 1.89 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 1214 / 28717 (4.2%) | 29521 / 287170 (10.3%) | −289.8 | −287.5 | 0.41 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 755 / 28717 (2.6%) | 22509 / 287170 (7.8%) | −289.2 | −286.9 | 0.34 |
| MEN1 SRX14030481 | MV-4-11 Blood | 1538 / 28717 (5.4%) | 4746 / 287170 (1.7%) | −289.2 | −286.9 | 3.24 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1791 / 28717 (6.2%) | 37591 / 287170 (13.1%) | −288.6 | −286.3 | 0.48 |
| KAT7 DRX234808 | 293 Kidney | 1316 / 28717 (4.6%) | 3601 / 287170 (1.3%) | −287.2 | −285.0 | 3.65 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1811 / 28717 (6.3%) | 37807 / 287170 (13.2%) | −287.2 | −284.9 | 0.48 |
| BRD4 SRX12129503 | T cells Blood | 1933 / 28717 (6.7%) | 7029 / 287170 (2.4%) | −287.1 | −284.9 | 2.75 |
| PBX3 SRX190343 | SK-N-SH Neural | 1307 / 28717 (4.6%) | 30763 / 287170 (10.7%) | −287.0 | −284.8 | 0.42 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 1215 / 28717 (4.2%) | 29427 / 287170 (10.2%) | −287.0 | −284.7 | 0.41 |
| ESR1 SRX371467 | MCF-7 Breast | 672 / 28717 (2.3%) | 21036 / 287170 (7.3%) | −285.4 | −283.1 | 0.32 |
| CHD1 SRX186771 | K-562 Blood | 1236 / 28717 (4.3%) | 3226 / 287170 (1.1%) | −284.8 | −282.5 | 3.83 |
| TP53 SRX19538279 | Osteoblasts Bone | 547 / 28717 (1.9%) | 480 / 287170 (0.2%) | −284.6 | −282.3 | 11.40 |
| KMT2A SRX1424881 | SEM Blood | 1892 / 28717 (6.6%) | 6831 / 287170 (2.4%) | −284.0 | −281.7 | 2.77 |
| EZH2 SRX4212591 | Peripheral blood mononuclear cells Blood | 1382 / 28717 (4.8%) | 3976 / 287170 (1.4%) | −284.0 | −281.7 | 3.48 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 759 / 28717 (2.6%) | 22372 / 287170 (7.8%) | −283.4 | −281.1 | 0.34 |
| EP300 SRX150579 | HeLa Uterus | 386 / 28717 (1.3%) | 16032 / 287170 (5.6%) | −283.2 | −280.9 | 0.24 |
| ESR1 SRX4367192 | MCF-7 Breast | 1295 / 28717 (4.5%) | 30438 / 287170 (10.6%) | −283.0 | −280.8 | 0.43 |
| RUVBL2 SRX9424449 | GM12878 Blood | 3090 / 28717 (10.8%) | 14646 / 287170 (5.1%) | −282.8 | −280.6 | 2.11 |
| JUN SRX7277180 | GM07492 Others | 495 / 28717 (1.7%) | 17960 / 287170 (6.3%) | −282.5 | −280.3 | 0.28 |
| AFF1 SRX2281250 | SEM Blood | 1628 / 28717 (5.7%) | 5331 / 287170 (1.9%) | −282.2 | −280.0 | 3.05 |
| GATA3 SRX190239 | MCF-7 Breast | 959 / 28717 (3.3%) | 25428 / 287170 (8.9%) | −281.8 | −279.5 | 0.38 |
| SETD1A SRX23734394 | MOLM-13 Blood | 1738 / 28717 (6.1%) | 5972 / 287170 (2.1%) | −281.1 | −278.9 | 2.91 |
| MYC SRX1497384 | RAJI Blood | 1635 / 28717 (5.7%) | 5387 / 287170 (1.9%) | −280.9 | −278.7 | 3.04 |
| EP300 SRX2194266 | SUM 159PT Breast | 1097 / 28717 (3.8%) | 27405 / 287170 (9.5%) | −279.3 | −277.1 | 0.40 |
| WWTR1 SRX10119367 | MCF 10A Breast | 732 / 28717 (2.5%) | 21784 / 287170 (7.6%) | −278.7 | −276.5 | 0.34 |
| RUVBL2 SRX9424448 | GM12878 Blood | 2908 / 28717 (10.1%) | 13479 / 287170 (4.7%) | −278.7 | −276.5 | 2.16 |
| ESR1 SRX194569 | MCF-7 Breast | 681 / 28717 (2.4%) | 20959 / 287170 (7.3%) | −278.7 | −276.4 | 0.32 |
| PRRX1 SRX15235713 | Hs 578T Breast | 766 / 28717 (2.7%) | 22303 / 287170 (7.8%) | −278.1 | −275.9 | 0.34 |
| ESR1 SRX10365536 | MCF-7 Breast | 323 / 28717 (1.1%) | 14690 / 287170 (5.1%) | −277.8 | −275.6 | 0.22 |
| ESR1 SRX20282973 | MCF-7 Breast | 773 / 28717 (2.7%) | 22399 / 287170 (7.8%) | −277.7 | −275.5 | 0.35 |
| KMT2A SRX14127515 | OCI-AML3 Blood | 1811 / 28717 (6.3%) | 6451 / 287170 (2.2%) | −277.5 | −275.3 | 2.81 |
| FOXA1 SRX1161173 | MCF-7 Breast | 523 / 28717 (1.8%) | 18266 / 287170 (6.4%) | −276.9 | −274.7 | 0.29 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 936 / 28717 (3.3%) | 24904 / 287170 (8.7%) | −276.9 | −274.7 | 0.38 |
| FOXA1 SRX371481 | MCF-7 Breast | 710 / 28717 (2.5%) | 21358 / 287170 (7.4%) | −276.5 | −274.3 | 0.33 |
| GATA3 SRX5057632 | MCF-7 Breast | 413 / 28717 (1.4%) | 16312 / 287170 (5.7%) | −276.3 | −274.1 | 0.25 |
| BRD2 SRX10760645 | MM.1S Blood | 3118 / 28717 (10.9%) | 14995 / 287170 (5.2%) | −276.1 | −273.9 | 2.08 |
| DOT1L SRX12416059 | MV-4-11 Blood | 2149 / 28717 (7.5%) | 8533 / 287170 (3.0%) | −275.9 | −273.7 | 2.52 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 1117 / 28717 (3.9%) | 27566 / 287170 (9.6%) | −275.6 | −273.4 | 0.41 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 537 / 28717 (1.9%) | 18453 / 287170 (6.4%) | −275.3 | −273.0 | 0.29 |
| MYC SRX13134693 | 293 Kidney | 2188 / 28717 (7.6%) | 8792 / 287170 (3.1%) | −275.1 | −272.9 | 2.49 |
| RAC1 SRX10365543 | MCF-7 Breast | 328 / 28717 (1.1%) | 14698 / 287170 (5.1%) | −274.9 | −272.7 | 0.22 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 1116 / 28717 (3.9%) | 27492 / 287170 (9.6%) | −274.1 | −271.9 | 0.41 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 2009 / 28717 (7.0%) | 7695 / 287170 (2.7%) | −274.0 | −271.8 | 2.61 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 379 / 28717 (1.3%) | 15619 / 287170 (5.4%) | −273.7 | −271.5 | 0.24 |
| FOXA1 SRX1161175 | MCF-7 Breast | 491 / 28717 (1.7%) | 17609 / 287170 (6.1%) | −273.7 | −271.5 | 0.28 |
| RELA SRX2207673 | HUVEC Cardiovascular | 2298 / 28717 (8.0%) | 43682 / 287170 (15.2%) | −273.6 | −271.4 | 0.53 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 859 / 28717 (3.0%) | 23590 / 287170 (8.2%) | −273.3 | −271.1 | 0.36 |
| FOXA1 SRX371483 | MCF-7 Breast | 765 / 28717 (2.7%) | 22110 / 287170 (7.7%) | −273.0 | −270.8 | 0.35 |
| FOXA1 SRX4815198 | MCF-7 Breast | 2153 / 28717 (7.5%) | 41753 / 287170 (14.5%) | −272.8 | −270.6 | 0.52 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 1095 / 28717 (3.8%) | 2664 / 287170 (0.9%) | −272.2 | −270.0 | 4.11 |
| FOXA1 SRX4815197 | MCF-7 Breast | 1595 / 28717 (5.6%) | 34228 / 287170 (11.9%) | −272.1 | −269.9 | 0.47 |
| TLE3 SRX4815191 | MCF-7 Breast | 648 / 28717 (2.3%) | 20192 / 287170 (7.0%) | −271.9 | −269.7 | 0.32 |
| JUNB SRX10119384 | MCF 10A Breast | 367 / 28717 (1.3%) | 15316 / 287170 (5.3%) | −271.2 | −269.0 | 0.24 |
| GATA3 SRX176864 | MCF-7 Breast | 482 / 28717 (1.7%) | 17372 / 287170 (6.0%) | −271.1 | −269.0 | 0.28 |
| TP53 SRX19538268 | U2OS Bone | 455 / 28717 (1.6%) | 294 / 287170 (0.1%) | −270.9 | −268.7 | 15.48 |
| TP53 SRX19538274 | U2OS Bone | 453 / 28717 (1.6%) | 291 / 287170 (0.1%) | −270.3 | −268.1 | 15.57 |
| BCOR SRX130609 | B cells Blood | 3203 / 28717 (11.2%) | 15743 / 287170 (5.5%) | −269.8 | −267.6 | 2.03 |
| EP300 SRX2194265 | SUM 159PT Breast | 1013 / 28717 (3.5%) | 25802 / 287170 (9.0%) | −269.8 | −267.6 | 0.39 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 517 / 28717 (1.8%) | 17929 / 287170 (6.2%) | −269.6 | −267.5 | 0.29 |
| FOXA1 SRX371482 | MCF-7 Breast | 978 / 28717 (3.4%) | 25271 / 287170 (8.8%) | −269.6 | −267.4 | 0.39 |
| RBFOX2 SRX4708082 | K-562 Blood | 3867 / 28717 (13.5%) | 20584 / 287170 (7.2%) | −269.4 | −267.3 | 1.88 |
| FOXA1 SRX1161176 | MCF-7 Breast | 650 / 28717 (2.3%) | 20130 / 287170 (7.0%) | −269.1 | −266.9 | 0.32 |
| NR3C1 SRX10976921 | A549 Lung | 433 / 28717 (1.5%) | 16433 / 287170 (5.7%) | −268.7 | −266.5 | 0.26 |
| ESR1 SRX371468 | MCF-7 Breast | 424 / 28717 (1.5%) | 16258 / 287170 (5.7%) | −268.1 | −266.0 | 0.26 |
| SUPT5H SRX2059875 | BJAB Blood | 2737 / 28717 (9.5%) | 12555 / 287170 (4.4%) | −267.4 | −265.3 | 2.18 |
| MLLT6 DRX059637 | 293 Kidney | 664 / 28717 (2.3%) | 912 / 287170 (0.3%) | −267.2 | −265.1 | 7.28 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 709 / 28717 (2.5%) | 20990 / 287170 (7.3%) | −266.4 | −264.2 | 0.34 |
| ESR1 SRX20282955 | MCF-7 Breast | 697 / 28717 (2.4%) | 20785 / 287170 (7.2%) | −265.9 | −263.8 | 0.34 |
| RAC1 SRX10365541 | MCF-7 Breast | 343 / 28717 (1.2%) | 14711 / 287170 (5.1%) | −265.9 | −263.8 | 0.23 |
| MYC SRX5346116 | RAMOS Blood | 1740 / 28717 (6.1%) | 6208 / 287170 (2.2%) | −265.5 | −263.4 | 2.80 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 876 / 28717 (3.1%) | 23559 / 287170 (8.2%) | −265.0 | −262.9 | 0.37 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 616 / 28717 (2.1%) | 19438 / 287170 (6.8%) | −265.0 | −262.9 | 0.32 |
| AR SRX10820653 | LNCAP Prostate | 445 / 28717 (1.5%) | 288 / 287170 (0.1%) | −264.7 | −262.6 | 15.45 |
| ESR1 SRX194572 | MCF-7 Breast | 425 / 28717 (1.5%) | 16166 / 287170 (5.6%) | −264.7 | −262.5 | 0.26 |
| BCOR SRX689472 | OCI-LY1 Blood | 2708 / 28717 (9.4%) | 12436 / 287170 (4.3%) | −263.8 | −261.7 | 2.18 |
| AFF1 SRX9560790 | Spleen Others | 907 / 28717 (3.2%) | 1884 / 287170 (0.7%) | −263.5 | −261.4 | 4.81 |
| KMT2A SRX10484574 | RS4-11 Blood | 3552 / 28717 (12.4%) | 18427 / 287170 (6.4%) | −263.3 | −261.1 | 1.93 |
| ARID1A SRX5089376 | MCF-7 Breast | 575 / 28717 (2.0%) | 18696 / 287170 (6.5%) | −263.2 | −261.1 | 0.31 |
| STAT3 SRX150479 | MCF 10A Breast | 604 / 28717 (2.1%) | 19170 / 287170 (6.7%) | −263.0 | −260.9 | 0.32 |
| CHD1 SRX116417 | K-562 Blood | 1129 / 28717 (3.9%) | 2924 / 287170 (1.0%) | −262.1 | −260.0 | 3.86 |
| ESR1 SRX20282940 | MCF-7 Breast | 726 / 28717 (2.5%) | 21090 / 287170 (7.3%) | −261.4 | −259.3 | 0.34 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 983 / 28717 (3.4%) | 25045 / 287170 (8.7%) | −261.4 | −259.2 | 0.39 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 515 / 28717 (1.8%) | 17609 / 287170 (6.1%) | −260.8 | −258.7 | 0.29 |
| HDAC1 SRX17989496 | PBMC Blood | 2386 / 28717 (8.3%) | 10339 / 287170 (3.6%) | −260.7 | −258.6 | 2.31 |
| HDAC1 SRX17989498 | PBMC Blood | 2527 / 28717 (8.8%) | 11275 / 287170 (3.9%) | −260.7 | −258.6 | 2.24 |
| STAT3 SRX150630 | MCF 10A Breast | 603 / 28717 (2.1%) | 19074 / 287170 (6.6%) | −260.5 | −258.4 | 0.32 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 476 / 28717 (1.7%) | 16927 / 287170 (5.9%) | −260.4 | −258.3 | 0.28 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 442 / 28717 (1.5%) | 16320 / 287170 (5.7%) | −260.0 | −257.9 | 0.27 |
| MYC SRX1539275 | P493-6 Blood | 1801 / 28717 (6.3%) | 6666 / 287170 (2.3%) | −259.3 | −257.2 | 2.70 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 2480 / 28717 (8.6%) | 10995 / 287170 (3.8%) | −259.1 | −257.0 | 2.26 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 639 / 28717 (2.2%) | 19565 / 287170 (6.8%) | −257.7 | −255.6 | 0.33 |
| NR3C1 SRX10977357 | A549 Lung | 389 / 28717 (1.4%) | 15297 / 287170 (5.3%) | −257.5 | −255.4 | 0.25 |
| BRD4 SRX20304302 | NB-4 Blood | 1641 / 28717 (5.7%) | 5747 / 287170 (2.0%) | −257.4 | −255.3 | 2.86 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 606 / 28717 (2.1%) | 19019 / 287170 (6.6%) | −257.4 | −255.3 | 0.32 |
| Epitope tags SRX2529781 | RAJI Blood | 1684 / 28717 (5.9%) | 6000 / 287170 (2.1%) | −257.3 | −255.2 | 2.81 |
| ESR1 SRX371477 | MCF-7 Breast | 326 / 28717 (1.1%) | 14131 / 287170 (4.9%) | −257.3 | −255.2 | 0.23 |
| RELA SRX2207672 | HUVEC Cardiovascular | 2516 / 28717 (8.8%) | 45700 / 287170 (15.9%) | −256.4 | −254.3 | 0.55 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 1001 / 28717 (3.5%) | 25113 / 287170 (8.7%) | −256.0 | −253.9 | 0.40 |
| WWTR1 SRX10119378 | MCF 10A Breast | 716 / 28717 (2.5%) | 20745 / 287170 (7.2%) | −256.0 | −253.9 | 0.35 |
| MED1 SRX8807165 | MOLM-13 Blood | 1296 / 28717 (4.5%) | 3845 / 287170 (1.3%) | −255.8 | −253.7 | 3.37 |
| TLE3 SRX4815194 | SUM 149PT Breast | 494 / 28717 (1.7%) | 17078 / 287170 (5.9%) | −255.5 | −253.4 | 0.29 |
| BCL6 SRX689470 | OCI-LY1 Blood | 3256 / 28717 (11.3%) | 16484 / 287170 (5.7%) | −255.1 | −253.0 | 1.98 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 1409 / 28717 (4.9%) | 4465 / 287170 (1.6%) | −255.0 | −252.9 | 3.16 |
| ARID1A SRX5679788 | 12Z Others | 258 / 28717 (0.9%) | 12727 / 287170 (4.4%) | −254.0 | −251.9 | 0.20 |
| ETS1 SRX9046311 | THP-1 Blood | 1784 / 28717 (6.2%) | 6656 / 287170 (2.3%) | −253.5 | −251.4 | 2.68 |
| YAP1 SRX1038945 | IMR-90 Lung | 493 / 28717 (1.7%) | 16979 / 287170 (5.9%) | −253.0 | −250.9 | 0.29 |
| ESR1 SRX330067 | MCF-7 Breast | 611 / 28717 (2.1%) | 18939 / 287170 (6.6%) | −252.8 | −250.7 | 0.32 |
| KMT2D SRX971780 | OCI-LY-7 Blood | 3244 / 28717 (11.3%) | 16475 / 287170 (5.7%) | −252.2 | −250.1 | 1.97 |
| ESR1 SRX2881000 | MCF-7 Breast | 594 / 28717 (2.1%) | 18639 / 287170 (6.5%) | −252.1 | −250.0 | 0.32 |
| TP53 SRX19538267 | U2OS Bone | 415 / 28717 (1.4%) | 257 / 287170 (0.1%) | −251.2 | −249.1 | 16.15 |
| TP53 SRX19538276 | U2OS Bone | 442 / 28717 (1.5%) | 320 / 287170 (0.1%) | −251.1 | −249.0 | 13.81 |
| BRD4 SRX3591432 | B-CLL cells Blood | 1842 / 28717 (6.4%) | 7053 / 287170 (2.5%) | −250.7 | −248.6 | 2.61 |
| ESR1 SRX2881002 | MCF-7 Breast | 646 / 28717 (2.2%) | 19415 / 287170 (6.8%) | −250.0 | −247.9 | 0.33 |
| WWTR1 SRX10119368 | MCF 10A Breast | 462 / 28717 (1.6%) | 16342 / 287170 (5.7%) | −249.7 | −247.6 | 0.28 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 792 / 28717 (2.8%) | 1504 / 287170 (0.5%) | −249.1 | −247.1 | 5.27 |
| ARID1A SRX5679787 | 12Z Others | 243 / 28717 (0.8%) | 12262 / 287170 (4.3%) | −248.3 | −246.2 | 0.20 |
| JUND SRX150408 | HeLa Uterus | 596 / 28717 (2.1%) | 18519 / 287170 (6.4%) | −247.6 | −245.5 | 0.32 |
| AR SRX1067067 | LHSAR Prostate | 1158 / 28717 (4.0%) | 27087 / 287170 (9.4%) | −247.6 | −245.5 | 0.43 |
| BMI1 SRX644729 | 293 Kidney | 361 / 28717 (1.3%) | 157 / 287170 (0.1%) | −246.7 | −244.6 | 22.99 |
| ESR1 SRX20282938 | MCF-7 Breast | 547 / 28717 (1.9%) | 17681 / 287170 (6.2%) | −246.6 | −244.6 | 0.31 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 881 / 28717 (3.1%) | 22954 / 287170 (8.0%) | −246.4 | −244.3 | 0.38 |
| RBFOX2 SRX3322782 | K-562 Blood | 3049 / 28717 (10.6%) | 15227 / 287170 (5.3%) | −246.2 | −244.1 | 2.00 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 1027 / 28717 (3.6%) | 25113 / 287170 (8.7%) | −245.9 | −243.8 | 0.41 |
| KMT2A SRX5732677 | MOLM-13 Blood | 1648 / 28717 (5.7%) | 5979 / 287170 (2.1%) | −244.6 | −242.5 | 2.76 |
| ESR1 SRX371471 | ZR-75-1 Breast | 785 / 28717 (2.7%) | 21416 / 287170 (7.5%) | −244.4 | −242.4 | 0.37 |
| NR3C1 SRX10977372 | A549 Lung | 381 / 28717 (1.3%) | 14744 / 287170 (5.1%) | −244.4 | −242.4 | 0.26 |
| BCOR SRX10184500 | Acute myeloid leukemia Blood | 2623 / 28717 (9.1%) | 12289 / 287170 (4.3%) | −243.9 | −241.9 | 2.13 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 705 / 28717 (2.5%) | 20116 / 287170 (7.0%) | −243.1 | −241.1 | 0.35 |
| CEBPB SRX150632 | HeLa Uterus | 1545 / 28717 (5.4%) | 32337 / 287170 (11.3%) | −243.1 | −241.0 | 0.48 |
| FOS SRX070879 | HUVEC Cardiovascular | 732 / 28717 (2.5%) | 20525 / 287170 (7.1%) | −242.7 | −240.6 | 0.36 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 647 / 28717 (2.3%) | 19171 / 287170 (6.7%) | −242.5 | −240.4 | 0.34 |
| RBFOX2 SRX3322781 | K-562 Blood | 3210 / 28717 (11.2%) | 16484 / 287170 (5.7%) | −242.4 | −240.3 | 1.95 |
| ESR1 SRX20282971 | MCF-7 Breast | 690 / 28717 (2.4%) | 19843 / 287170 (6.9%) | −242.1 | −240.0 | 0.35 |
| ESR1 SRX20282953 | MCF-7 Breast | 569 / 28717 (2.0%) | 17888 / 287170 (6.2%) | −242.0 | −240.0 | 0.32 |
| EP300 SRX10976215 | A549 Lung | 627 / 28717 (2.2%) | 18833 / 287170 (6.6%) | −242.0 | −239.9 | 0.33 |
| ESR1 SRX330069 | MCF-7 Breast | 421 / 28717 (1.5%) | 15374 / 287170 (5.4%) | −241.9 | −239.8 | 0.27 |
| FOXA1 SRX371480 | MCF-7 Breast | 495 / 28717 (1.7%) | 16642 / 287170 (5.8%) | −241.7 | −239.7 | 0.30 |
| EP300 SRX100540 | SK-N-SH Neural | 999 / 28717 (3.5%) | 24535 / 287170 (8.5%) | −241.5 | −239.5 | 0.41 |
| Epitope tags SRX2745846 | MCF 10A Breast | 440 / 28717 (1.5%) | 15688 / 287170 (5.5%) | −241.3 | −239.3 | 0.28 |
| NFIC SRX190336 | SK-N-SH Neural | 964 / 28717 (3.4%) | 24011 / 287170 (8.4%) | −241.3 | −239.3 | 0.40 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 1208 / 28717 (4.2%) | 27552 / 287170 (9.6%) | −241.1 | −239.0 | 0.44 |
| BRD4 SRX3591436 | B-CLL cells Blood | 939 / 28717 (3.3%) | 2213 / 287170 (0.8%) | −241.0 | −239.0 | 4.24 |
| BRD4 SRX20304308 | NB-4 Blood | 1170 / 28717 (4.1%) | 3353 / 287170 (1.2%) | −240.9 | −238.9 | 3.49 |
| BRD4 SRX3591428 | B-CLL cells Blood | 1927 / 28717 (6.7%) | 7753 / 287170 (2.7%) | −240.5 | −238.5 | 2.49 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 497 / 28717 (1.7%) | 16627 / 287170 (5.8%) | −240.3 | −238.2 | 0.30 |
| FOXA1 SRX3931044 | MCF-7 Breast | 1503 / 28717 (5.2%) | 31629 / 287170 (11.0%) | −239.9 | −237.9 | 0.48 |
| KMT2A SRX20870812 | SEM Blood | 1784 / 28717 (6.2%) | 6897 / 287170 (2.4%) | −238.6 | −236.5 | 2.59 |
| ESR1 SRX10365558 | MCF-7 Breast | 471 / 28717 (1.6%) | 16124 / 287170 (5.6%) | −238.3 | −236.2 | 0.29 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 678 / 28717 (2.4%) | 19517 / 287170 (6.8%) | −238.2 | −236.2 | 0.35 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 740 / 28717 (2.6%) | 20469 / 287170 (7.1%) | −237.5 | −235.5 | 0.36 |
| DAXX SRX1021630 | PC-3 Prostate | 703 / 28717 (2.4%) | 19871 / 287170 (6.9%) | −237.1 | −235.1 | 0.35 |
| MED1 SRX13134691 | 293 Kidney | 1786 / 28717 (6.2%) | 6938 / 287170 (2.4%) | −236.9 | −234.9 | 2.57 |
| JUNB SRX10119385 | MCF 10A Breast | 305 / 28717 (1.1%) | 13109 / 287170 (4.6%) | −236.6 | −234.6 | 0.23 |
| MYC SRX5391526 | RAJI Blood | 1597 / 28717 (5.6%) | 5799 / 287170 (2.0%) | −236.5 | −234.5 | 2.75 |
| ESR1 SRX1469949 | MCF-7 Breast | 397 / 28717 (1.4%) | 14767 / 287170 (5.1%) | −236.1 | −234.1 | 0.27 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 926 / 28717 (3.2%) | 23242 / 287170 (8.1%) | −235.9 | −233.9 | 0.40 |
| JUN SRX6582163 | BJ-5ta Epidermis | 877 / 28717 (3.1%) | 22503 / 287170 (7.8%) | −235.9 | −233.9 | 0.39 |
| FOS SRX150664 | HUVEC Cardiovascular | 925 / 28717 (3.2%) | 23217 / 287170 (8.1%) | −235.6 | −233.6 | 0.40 |
| ESR1 SRX371470 | ZR-75-1 Breast | 681 / 28717 (2.4%) | 19473 / 287170 (6.8%) | −235.5 | −233.5 | 0.35 |
| MED1 SRX13134690 | 293 Kidney | 1896 / 28717 (6.6%) | 7648 / 287170 (2.7%) | −235.4 | −233.4 | 2.48 |
| STAT3 SRX150536 | MCF 10A Breast | 786 / 28717 (2.7%) | 21099 / 287170 (7.3%) | −235.3 | −233.3 | 0.37 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 551 / 28717 (1.9%) | 17367 / 287170 (6.0%) | −235.3 | −233.3 | 0.32 |
| TEAD1 SRX716558 | SF268 Neural | 344 / 28717 (1.2%) | 13789 / 287170 (4.8%) | −235.2 | −233.2 | 0.25 |
| SETD1A SRX23734395 | MOLM-13 Blood | 1348 / 28717 (4.7%) | 4384 / 287170 (1.5%) | −235.0 | −233.0 | 3.07 |
| ESR1 SRX11120903 | MCF-7 Breast | 609 / 28717 (2.1%) | 18296 / 287170 (6.4%) | −234.8 | −232.8 | 0.33 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 528 / 28717 (1.8%) | 16968 / 287170 (5.9%) | −234.8 | −232.8 | 0.31 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 2084 / 28717 (7.3%) | 8867 / 287170 (3.1%) | −234.8 | −232.8 | 2.35 |
| ESR1 SRX10365532 | MCF-7 Breast | 390 / 28717 (1.4%) | 14600 / 287170 (5.1%) | −234.7 | −232.7 | 0.27 |
| RAG1 SRX1898037 | REH Blood | 3449 / 28717 (12.0%) | 18455 / 287170 (6.4%) | −234.4 | −232.4 | 1.87 |
| JUN SRX6582165 | BJ-5ta Epidermis | 1324 / 28717 (4.6%) | 28906 / 287170 (10.1%) | −234.1 | −232.1 | 0.46 |
| FOS SRX3322636 | MCF-7 Breast | 461 / 28717 (1.6%) | 15808 / 287170 (5.5%) | −233.9 | −231.9 | 0.29 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 1098 / 28717 (3.8%) | 25668 / 287170 (8.9%) | −233.5 | −231.5 | 0.43 |
| ESR1 SRX8537722 | MCF-7 Breast | 662 / 28717 (2.3%) | 19091 / 287170 (6.6%) | −233.3 | −231.3 | 0.35 |
| FOXA1 SRX11222437 | MCF-7 Breast | 523 / 28717 (1.8%) | 16831 / 287170 (5.9%) | −233.3 | −231.3 | 0.31 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 336 / 28717 (1.2%) | 13576 / 287170 (4.7%) | −233.1 | −231.1 | 0.25 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 936 / 28717 (3.3%) | 23277 / 287170 (8.1%) | −232.9 | −230.9 | 0.40 |
| SSRP1 SRX3436567 | HT-1080 Bone | 599 / 28717 (2.1%) | 865 / 287170 (0.3%) | −232.9 | −230.9 | 6.92 |
| ESR1 SRX330070 | MCF-7 Breast | 366 / 28717 (1.3%) | 14111 / 287170 (4.9%) | −232.9 | −230.9 | 0.26 |
| JUN SRX2355072 | HAEC Cardiovascular | 930 / 28717 (3.2%) | 23167 / 287170 (8.1%) | −232.4 | −230.5 | 0.40 |
| JUND SRX699738 | HCASMC Cardiovascular | 983 / 28717 (3.4%) | 23947 / 287170 (8.3%) | −232.2 | −230.3 | 0.41 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 790 / 28717 (2.8%) | 1619 / 287170 (0.6%) | −232.2 | −230.2 | 4.88 |
| EP300 SRX10976625 | A549 Lung | 405 / 28717 (1.4%) | 14756 / 287170 (5.1%) | −231.4 | −229.4 | 0.27 |
| KMT2A SRX15203357 | Acute lymphoid leukemia Blood | 2737 / 28717 (9.5%) | 13389 / 287170 (4.7%) | −230.8 | −228.8 | 2.04 |
| TAF1 SRX11120885 | MCF-7 Breast | 2686 / 28717 (9.4%) | 13032 / 287170 (4.5%) | −230.7 | −228.7 | 2.06 |
| NR3C1 SRX10977373 | A549 Lung | 379 / 28717 (1.3%) | 14265 / 287170 (5.0%) | −230.4 | −228.4 | 0.27 |
| Epitope tags SRX12416065 | MOLM-13 Blood | 681 / 28717 (2.4%) | 1186 / 287170 (0.4%) | −230.1 | −228.1 | 5.74 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 1733 / 28717 (6.0%) | 34308 / 287170 (11.9%) | −230.0 | −228.0 | 0.51 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 519 / 28717 (1.8%) | 16645 / 287170 (5.8%) | −229.6 | −227.6 | 0.31 |
| TLE3 SRX4815192 | MCF-7 Breast | 662 / 28717 (2.3%) | 18943 / 287170 (6.6%) | −229.0 | −227.1 | 0.35 |
| FOSL2 SRX190204 | A549 Lung | 706 / 28717 (2.5%) | 19627 / 287170 (6.8%) | −228.9 | −226.9 | 0.36 |
| ESR1 SRX20282946 | MCF-7 Breast | 440 / 28717 (1.5%) | 15287 / 287170 (5.3%) | −228.9 | −226.9 | 0.29 |
| EP300 SRX190219 | SK-N-SH Neural | 698 / 28717 (2.4%) | 19481 / 287170 (6.8%) | −228.3 | −226.4 | 0.36 |
| SUPT5H SRX2314263 | MOLT-4 Blood | 2664 / 28717 (9.3%) | 12939 / 287170 (4.5%) | −228.2 | −226.2 | 2.06 |
| AR SRX1067066 | LHSAR Prostate | 1484 / 28717 (5.2%) | 30863 / 287170 (10.7%) | −228.0 | −226.1 | 0.48 |
| GFP SRX6949256 | HeLa Uterus | 785 / 28717 (2.7%) | 20806 / 287170 (7.2%) | −227.7 | −225.8 | 0.38 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 909 / 28717 (3.2%) | 2195 / 287170 (0.8%) | −227.3 | −225.4 | 4.14 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 651 / 28717 (2.3%) | 18692 / 287170 (6.5%) | −227.0 | −225.0 | 0.35 |
| MEN1 SRX11712606 | K-562 Blood | 1353 / 28717 (4.7%) | 4519 / 287170 (1.6%) | −226.9 | −225.0 | 2.99 |
| FOXA1 SRX1161174 | MCF-7 Breast | 768 / 28717 (2.7%) | 20509 / 287170 (7.1%) | −226.7 | −224.7 | 0.37 |
| GATA1 SRX097108 | K-562 Blood | 2442 / 28717 (8.5%) | 11430 / 287170 (4.0%) | −226.7 | −224.7 | 2.14 |
| JUNB SRX2443774 | A549 Lung | 302 / 28717 (1.1%) | 12746 / 287170 (4.4%) | −226.5 | −224.6 | 0.24 |
| NR3C1 SRX17639412 | A549 Lung | 804 / 28717 (2.8%) | 21034 / 287170 (7.3%) | −226.0 | −224.0 | 0.38 |
| ESR1 SRX3110725 | MCF-7 Breast | 655 / 28717 (2.3%) | 18716 / 287170 (6.5%) | −225.9 | −223.9 | 0.35 |
| ESR1 SRX2912055 | MCF-7 Breast | 275 / 28717 (1.0%) | 12219 / 287170 (4.3%) | −225.8 | −223.8 | 0.23 |
| FOXA1 SRX190181 | A549 Lung | 520 / 28717 (1.8%) | 16530 / 287170 (5.8%) | −225.7 | −223.7 | 0.31 |
| KMT2A SRX5668134 | IMS-M2 Blood | 1120 / 28717 (3.9%) | 3264 / 287170 (1.1%) | −225.6 | −223.7 | 3.43 |
| XPO1 SRX14127501 | OCI-AML3 Blood | 792 / 28717 (2.8%) | 1680 / 287170 (0.6%) | −225.4 | −223.4 | 4.71 |
| ESR1 SRX1531796 | MCF-7 Breast | 387 / 28717 (1.3%) | 14250 / 287170 (5.0%) | −225.3 | −223.4 | 0.27 |
| ESR1 SRX2513517 | MCF-7 Breast | 490 / 28717 (1.7%) | 16001 / 287170 (5.6%) | −224.9 | −223.0 | 0.31 |
| EP300 SRX176885 | MCF-7 Breast | 382 / 28717 (1.3%) | 14138 / 287170 (4.9%) | −224.7 | −222.8 | 0.27 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 1033 / 28717 (3.6%) | 24379 / 287170 (8.5%) | −224.6 | −222.7 | 0.42 |
| Epitope tags SRX10715360 | HCB1 Blood | 1755 / 28717 (6.1%) | 6954 / 287170 (2.4%) | −224.5 | −222.6 | 2.52 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1603 / 28717 (5.6%) | 32312 / 287170 (11.3%) | −224.1 | −222.2 | 0.50 |
| RBM22 SRX4708083 | K-562 Blood | 1437 / 28717 (5.0%) | 5047 / 287170 (1.8%) | −223.7 | −221.8 | 2.85 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 896 / 28717 (3.1%) | 2167 / 287170 (0.8%) | −223.7 | −221.8 | 4.13 |
| FOXA1 SRX11222442 | MCF-7 Breast | 499 / 28717 (1.7%) | 16108 / 287170 (5.6%) | −223.6 | −221.6 | 0.31 |
| TP53 SRX19538273 | U2OS Bone | 387 / 28717 (1.3%) | 270 / 287170 (0.1%) | −223.3 | −221.4 | 14.33 |
| SMARCA4 SRX5982340 | A549 Lung | 288 / 28717 (1.0%) | 12379 / 287170 (4.3%) | −223.0 | −221.1 | 0.23 |
| ESR1 SRX2943591 | MCF-7 Breast | 528 / 28717 (1.8%) | 16561 / 287170 (5.8%) | −222.8 | −220.9 | 0.32 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 300 / 28717 (1.0%) | 12591 / 287170 (4.4%) | −222.7 | −220.8 | 0.24 |
| GFP SRX5417098 | HeLa Uterus | 843 / 28717 (2.9%) | 21498 / 287170 (7.5%) | −222.6 | −220.7 | 0.39 |
| TP53 SRX19538280 | Osteoblasts Bone | 425 / 28717 (1.5%) | 368 / 287170 (0.1%) | −222.5 | −220.6 | 11.55 |
| JUN SRX6582164 | BJ-5ta Epidermis | 911 / 28717 (3.2%) | 22511 / 287170 (7.8%) | −222.5 | −220.6 | 0.40 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 919 / 28717 (3.2%) | 2289 / 287170 (0.8%) | −222.3 | −220.4 | 4.01 |
| Epitope tags SRX1813533 | MV-4-11 Blood | 2674 / 28717 (9.3%) | 13150 / 287170 (4.6%) | −222.3 | −220.4 | 2.03 |
| ARID1A SRX5089379 | MCF-7 Breast | 735 / 28717 (2.6%) | 19835 / 287170 (6.9%) | −222.2 | −220.2 | 0.37 |
| AFF1 SRX15203355 | Acute lymphoid leukemia Blood | 622 / 28717 (2.2%) | 1009 / 287170 (0.4%) | −222.2 | −220.2 | 6.16 |
| ESR1 SRX1469951 | MCF-7 Breast | 378 / 28717 (1.3%) | 13983 / 287170 (4.9%) | −222.0 | −220.1 | 0.27 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 366 / 28717 (1.3%) | 13769 / 287170 (4.8%) | −221.9 | −220.0 | 0.27 |
| ESR1 SRX371474 | BT-474 Breast | 347 / 28717 (1.2%) | 13424 / 287170 (4.7%) | −221.9 | −219.9 | 0.26 |
| ESR1 SRX2881001 | MCF-7 Breast | 400 / 28717 (1.4%) | 14354 / 287170 (5.0%) | −221.6 | −219.6 | 0.28 |
| NKX2-1 SRX2164786 | A549 Lung | 1193 / 28717 (4.2%) | 26546 / 287170 (9.2%) | −221.5 | −219.5 | 0.45 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 2189 / 28717 (7.6%) | 9853 / 287170 (3.4%) | −220.3 | −218.4 | 2.22 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 630 / 28717 (2.2%) | 18113 / 287170 (6.3%) | −220.0 | −218.1 | 0.35 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 677 / 28717 (2.4%) | 18853 / 287170 (6.6%) | −219.9 | −218.0 | 0.36 |
| Epitope tags SRX10657969 | NALM-6 Blood | 3116 / 28717 (10.9%) | 16403 / 287170 (5.7%) | −219.8 | −217.9 | 1.90 |
| TEAD1 SRX3401272 | MCF-7 Breast | 574 / 28717 (2.0%) | 17209 / 287170 (6.0%) | −219.8 | −217.8 | 0.33 |
| KDM5A SRX8053100 | MM.1S Blood | 2343 / 28717 (8.2%) | 10907 / 287170 (3.8%) | −219.7 | −217.8 | 2.15 |
| AFF1 SRX4931279 | SEM Blood | 889 / 28717 (3.1%) | 2172 / 287170 (0.8%) | −219.5 | −217.6 | 4.09 |
| NR3C1 SRX10976392 | A549 Lung | 326 / 28717 (1.1%) | 12968 / 287170 (4.5%) | −219.4 | −217.5 | 0.25 |
| FOXA1 SRX1787653 | MCF-7 Breast | 626 / 28717 (2.2%) | 18029 / 287170 (6.3%) | −219.3 | −217.4 | 0.35 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 1326 / 28717 (4.6%) | 28296 / 287170 (9.9%) | −218.8 | −216.9 | 0.47 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 811 / 28717 (2.8%) | 20871 / 287170 (7.3%) | −218.8 | −216.9 | 0.39 |
| KMT2A SRX15203360 | Acute lymphoid leukemia Blood | 3777 / 28717 (13.2%) | 21408 / 287170 (7.5%) | −218.6 | −216.7 | 1.76 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 382 / 28717 (1.3%) | 13940 / 287170 (4.9%) | −218.5 | −216.6 | 0.27 |
| ESR1 SRX3123829 | MCF-7 Breast | 431 / 28717 (1.5%) | 14783 / 287170 (5.1%) | −218.3 | −216.4 | 0.29 |
| ESR1 SRX2513520 | MCF-7 Breast | 463 / 28717 (1.6%) | 15319 / 287170 (5.3%) | −218.0 | −216.1 | 0.30 |
| MEN1 SRX14030484 | MV-4-11 Blood | 1041 / 28717 (3.6%) | 2944 / 287170 (1.0%) | −217.6 | −215.7 | 3.54 |
| TP53 SRX19538275 | U2OS Bone | 392 / 28717 (1.4%) | 300 / 287170 (0.1%) | −217.4 | −215.5 | 13.07 |
| FOS SRX3322637 | MCF-7 Breast | 398 / 28717 (1.4%) | 14182 / 287170 (4.9%) | −217.4 | −215.5 | 0.28 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 1038 / 28717 (3.6%) | 24152 / 287170 (8.4%) | −216.9 | −215.0 | 0.43 |
| ESR1 SRX20282959 | MCF-7 Breast | 313 / 28717 (1.1%) | 12651 / 287170 (4.4%) | −216.9 | −215.0 | 0.25 |
| BRD4 SRX13134686 | 293 Kidney | 1811 / 28717 (6.3%) | 7453 / 287170 (2.6%) | −216.4 | −214.5 | 2.43 |
| ESR1 SRX371475 | BT-474 Breast | 393 / 28717 (1.4%) | 14061 / 287170 (4.9%) | −216.3 | −214.4 | 0.28 |
| NR3C1 SRX10977364 | A549 Lung | 321 / 28717 (1.1%) | 12777 / 287170 (4.4%) | −216.2 | −214.3 | 0.25 |
| FOXA1 SRX3923514 | MCF-7 Breast | 780 / 28717 (2.7%) | 20301 / 287170 (7.1%) | −216.1 | −214.2 | 0.38 |
| DOT1L SRX12416060 | MV-4-11 Blood | 900 / 28717 (3.1%) | 2257 / 287170 (0.8%) | −216.1 | −214.2 | 3.99 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 1044 / 28717 (3.6%) | 24199 / 287170 (8.4%) | −216.0 | −214.1 | 0.43 |
| RBBP5 SRX186645 | K-562 Blood | 2221 / 28717 (7.7%) | 10163 / 287170 (3.5%) | −215.9 | −214.0 | 2.19 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 2598 / 28717 (9.0%) | 12771 / 287170 (4.4%) | −215.8 | −213.9 | 2.03 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 606 / 28717 (2.1%) | 17581 / 287170 (6.1%) | −215.7 | −213.8 | 0.34 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 484 / 28717 (1.7%) | 15577 / 287170 (5.4%) | −215.2 | −213.3 | 0.31 |
| NR3C1 SRX18884271 | A549 Lung | 397 / 28717 (1.4%) | 14095 / 287170 (4.9%) | −215.1 | −213.2 | 0.28 |
| FOXA1 SRX5323843 | MCF-7 Breast | 398 / 28717 (1.4%) | 14111 / 287170 (4.9%) | −215.1 | −213.2 | 0.28 |
| PAF1 SRX15147186 | DLD-1 Digestive tract | 1233 / 28717 (4.3%) | 4004 / 287170 (1.4%) | −215.0 | −213.1 | 3.08 |
| AR SRX10820651 | LNCAP Prostate | 454 / 28717 (1.6%) | 479 / 287170 (0.2%) | −214.6 | −212.7 | 9.48 |
| CDK9 SRX9730735 | THP-1 Blood | 1533 / 28717 (5.3%) | 5755 / 287170 (2.0%) | −214.5 | −212.6 | 2.66 |
| WWTR1 SRX10119390 | MDA-MB-231 Breast | 270 / 28717 (0.9%) | 11777 / 287170 (4.1%) | −214.4 | −212.5 | 0.23 |
| TP53 SRX19538281 | Osteoblasts Bone | 466 / 28717 (1.6%) | 516 / 287170 (0.2%) | −214.3 | −212.4 | 9.03 |
| KMT2A SRX15213698 | SEM Blood | 2014 / 28717 (7.0%) | 8811 / 287170 (3.1%) | −214.2 | −212.4 | 2.29 |
| PBRM1 SRX8566576 | HK-2 Kidney | 2143 / 28717 (7.5%) | 9672 / 287170 (3.4%) | −214.2 | −212.3 | 2.22 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 725 / 28717 (2.5%) | 19372 / 287170 (6.7%) | −213.7 | −211.8 | 0.37 |
| KAT7 DRX300414 | 293 Kidney | 950 / 28717 (3.3%) | 2525 / 287170 (0.9%) | −213.7 | −211.8 | 3.76 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 980 / 28717 (3.4%) | 23177 / 287170 (8.1%) | −213.6 | −211.7 | 0.42 |
| ESR1 SRX10365533 | MCF-7 Breast | 367 / 28717 (1.3%) | 13516 / 287170 (4.7%) | −213.5 | −211.7 | 0.27 |
| ESR1 SRX1012629 | MCF-7 Breast | 481 / 28717 (1.7%) | 15468 / 287170 (5.4%) | −213.5 | −211.6 | 0.31 |
| KMT2A SRX2323891 | 293 Kidney | 1486 / 28717 (5.2%) | 5489 / 287170 (1.9%) | −213.5 | −211.6 | 2.71 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 944 / 28717 (3.3%) | 22643 / 287170 (7.9%) | −213.4 | −211.5 | 0.42 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 544 / 28717 (1.9%) | 16488 / 287170 (5.7%) | −213.0 | −211.1 | 0.33 |
| FOXA1 SRX11222441 | MCF-7 Breast | 599 / 28717 (2.1%) | 17370 / 287170 (6.0%) | −213.0 | −211.1 | 0.34 |
| BRD4 SRX2867630 | Lymphoblastoid cell line Blood | 3323 / 28717 (11.6%) | 18145 / 287170 (6.3%) | −212.5 | −210.7 | 1.83 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 804 / 28717 (2.8%) | 20527 / 287170 (7.1%) | −212.4 | −210.6 | 0.39 |
| DOT1L DRX411731 | 293 Kidney | 436 / 28717 (1.5%) | 435 / 287170 (0.2%) | −212.4 | −210.6 | 10.02 |
| YAP1 SRX10119363 | MCF 10A Breast | 323 / 28717 (1.1%) | 12694 / 287170 (4.4%) | −212.4 | −210.5 | 0.25 |
| ESR1 SRX8537723 | MCF-7 Breast | 613 / 28717 (2.1%) | 17554 / 287170 (6.1%) | −211.8 | −209.9 | 0.35 |
| FOXA1 SRX1787655 | MCF-7 Breast | 392 / 28717 (1.4%) | 13897 / 287170 (4.8%) | −211.8 | −209.9 | 0.28 |
| BRD4 SRX8272937 | BLaER1 Blood | 2012 / 28717 (7.0%) | 8851 / 287170 (3.1%) | −211.7 | −209.8 | 2.27 |
| MYC SRX10338563 | NALM-6 Blood | 2674 / 28717 (9.3%) | 13416 / 287170 (4.7%) | −211.6 | −209.8 | 1.99 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 952 / 28717 (3.3%) | 22684 / 287170 (7.9%) | −211.5 | −209.6 | 0.42 |
| FOXA1 SRX1787651 | MCF-7 Breast | 443 / 28717 (1.5%) | 14757 / 287170 (5.1%) | −211.3 | −209.5 | 0.30 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1968 / 28717 (6.9%) | 8569 / 287170 (3.0%) | −211.3 | −209.4 | 2.30 |
| PGR SRX1012655 | MCF-7 Breast | 496 / 28717 (1.7%) | 15636 / 287170 (5.4%) | −211.1 | −209.2 | 0.32 |
| FOXA1 SRX100454 | T-47D Breast | 994 / 28717 (3.5%) | 23277 / 287170 (8.1%) | −210.9 | −209.0 | 0.43 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 383 / 28717 (1.3%) | 13708 / 287170 (4.8%) | −210.8 | −208.9 | 0.28 |
| BCL6 SRX4609168 | SU-DHL-4 Blood | 2410 / 28717 (8.4%) | 11578 / 287170 (4.0%) | −210.6 | −208.8 | 2.08 |
| ESR1 SRX4451213 | MCF-7 Breast | 774 / 28717 (2.7%) | 19991 / 287170 (7.0%) | −210.3 | −208.4 | 0.39 |
| MAU2 SRX15710569 | RPE Neural | 710 / 28717 (2.5%) | 19011 / 287170 (6.6%) | −210.2 | −208.4 | 0.37 |
| Epitope tags SRX10657968 | NALM-6 Blood | 3014 / 28717 (10.5%) | 15924 / 287170 (5.5%) | −209.9 | −208.0 | 1.89 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 723 / 28717 (2.5%) | 1502 / 287170 (0.5%) | −209.7 | −207.9 | 4.81 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1878 / 28717 (6.5%) | 8011 / 287170 (2.8%) | −209.7 | −207.9 | 2.34 |
| RNF2 SRX18954719 | SCC-25 Others | 1007 / 28717 (3.5%) | 23397 / 287170 (8.1%) | −209.3 | −207.5 | 0.43 |
| Epitope tags SRX10657967 | NALM-6 Blood | 2919 / 28717 (10.2%) | 15251 / 287170 (5.3%) | −209.2 | −207.3 | 1.91 |
| ESR1 SRX2513521 | MCF-7 Breast | 368 / 28717 (1.3%) | 13347 / 287170 (4.6%) | −207.8 | −205.9 | 0.28 |
| ARID1A SRX5089385 | MCF-7 Breast | 579 / 28717 (2.0%) | 16871 / 287170 (5.9%) | −207.8 | −205.9 | 0.34 |
| SMARCA4 SRX5982364 | A549 Lung | 243 / 28717 (0.8%) | 11059 / 287170 (3.9%) | −207.6 | −205.8 | 0.22 |
| NR3C1 SRX2609668 | HASM2 Lung | 584 / 28717 (2.0%) | 16943 / 287170 (5.9%) | −207.6 | −205.7 | 0.34 |
| FOXA1 SRX028634 | MCF-7 Breast | 398 / 28717 (1.4%) | 13867 / 287170 (4.8%) | −207.6 | −205.7 | 0.29 |
| MED1 SRX3946904 | Mesenchymal stem cells Others | 370 / 28717 (1.3%) | 13372 / 287170 (4.7%) | −207.4 | −205.5 | 0.28 |
| NR3C1 SRX8520802 | HCC1187 Breast | 574 / 28717 (2.0%) | 16772 / 287170 (5.8%) | −207.3 | −205.4 | 0.34 |
| ESR1 SRX330068 | MCF-7 Breast | 371 / 28717 (1.3%) | 13380 / 287170 (4.7%) | −207.0 | −205.2 | 0.28 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 1149 / 28717 (4.0%) | 25330 / 287170 (8.8%) | −207.0 | −205.2 | 0.45 |
| FOXA1 SRX11222438 | MCF-7 Breast | 426 / 28717 (1.5%) | 14323 / 287170 (5.0%) | −207.0 | −205.2 | 0.30 |
| SMARCA4 SRX5982341 | A549 Lung | 234 / 28717 (0.8%) | 10867 / 287170 (3.8%) | −207.0 | −205.2 | 0.22 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 779 / 28717 (2.7%) | 19924 / 287170 (6.9%) | −206.4 | −204.6 | 0.39 |
| BRD4 SRX204410 | P493-6 Blood | 1935 / 28717 (6.7%) | 8448 / 287170 (2.9%) | −206.4 | −204.5 | 2.29 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 580 / 28717 (2.0%) | 16834 / 287170 (5.9%) | −206.3 | −204.4 | 0.34 |
| SMAD3 SRX366168 | NCI-H441 Lung | 667 / 28717 (2.3%) | 18203 / 287170 (6.3%) | −206.3 | −204.4 | 0.37 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 353 / 28717 (1.2%) | 13035 / 287170 (4.5%) | −206.2 | −204.4 | 0.27 |
| RBBP5 SRX116442 | K-562 Blood | 2192 / 28717 (7.6%) | 10182 / 287170 (3.5%) | −205.8 | −204.0 | 2.15 |
| Epitope tags SRX10657966 | NALM-6 Blood | 2973 / 28717 (10.4%) | 15739 / 287170 (5.5%) | −205.8 | −204.0 | 1.89 |
| FOXA1 SRX190282 | A549 Lung | 541 / 28717 (1.9%) | 16189 / 287170 (5.6%) | −205.7 | −203.9 | 0.33 |
| SMARCA2 SRX5982361 | A549 Lung | 251 / 28717 (0.9%) | 11147 / 287170 (3.9%) | −205.6 | −203.7 | 0.23 |
| ESR1 SRX2943589 | MCF-7 Breast | 409 / 28717 (1.4%) | 13973 / 287170 (4.9%) | −205.1 | −203.2 | 0.29 |
| Epitope tags SRX23734393 | MOLM-13 Blood | 782 / 28717 (2.7%) | 1803 / 287170 (0.6%) | −205.0 | −203.2 | 4.34 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 742 / 28717 (2.6%) | 19307 / 287170 (6.7%) | −205.0 | −203.1 | 0.38 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 496 / 28717 (1.7%) | 15420 / 287170 (5.4%) | −204.8 | −203.0 | 0.32 |
| ESR1 SRX1012632 | MCF-7 Breast | 396 / 28717 (1.4%) | 13730 / 287170 (4.8%) | −204.6 | −202.7 | 0.29 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 2037 / 28717 (7.1%) | 9168 / 287170 (3.2%) | −204.3 | −202.5 | 2.22 |
| AR SRX9469988 | LAPC-4 Prostate | 1021 / 28717 (3.6%) | 23399 / 287170 (8.1%) | −204.3 | −202.5 | 0.44 |
| CREBBP SRX7214025 | Keratinocytes Epidermis | 470 / 28717 (1.6%) | 14972 / 287170 (5.2%) | −204.2 | −202.4 | 0.31 |
| BRD4 SRX204905 | MM.1S Blood | 3223 / 28717 (11.2%) | 17650 / 287170 (6.1%) | −203.9 | −202.1 | 1.83 |
| FOXA1 SRX3923518 | MCF-7 Breast | 547 / 28717 (1.9%) | 16221 / 287170 (5.6%) | −203.9 | −202.1 | 0.34 |
| FOXA1 SRX13814018 | 5637 Others | 495 / 28717 (1.7%) | 15372 / 287170 (5.4%) | −203.9 | −202.0 | 0.32 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 846 / 28717 (2.9%) | 20816 / 287170 (7.2%) | −203.6 | −201.8 | 0.41 |
| FOXA1 SRX1787652 | MCF-7 Breast | 493 / 28717 (1.7%) | 15316 / 287170 (5.3%) | −203.2 | −201.4 | 0.32 |
Showing first 500 of 20174 rows.